Sort
39,280 grants matching “leukemia”
Annexin 2 in Angiogenesis
$422,500Katherine Amberson Hajjar · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · HL
The influence of genotype on the outcome of gene transfer in beta-thalassemia
$422,500Stefano Rivella · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · HL
Molecular basis of neutrophil spontaneous death
$422,500Hongbo R Luo · Boston Children'S Hospital · R01 · FY2010 · HL
Advancing CAR T cell therapy for solid tumors
$422,500Jalal Ahmed · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD
Role of ATM and RAG in maintaining genome stability during Tcra/d rearrangement.
$422,499Jane Amanda Skok · New York University School Of Medicine · R56 · FY2012 · AI
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
$422,496Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Eastern Cooperative Oncology Group Studies
$422,458Case Western Reserve University · U10 · FY2004 · CA
Systematic functional study of 21st chromosome ortholog overexpression in C. elegans
$422,421Jonathan T Pierce-Shimomura · University Of Texas At Austin · R21 · FY2022 · OD
Retroviral Coded Functions
$422,391Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Population-Based Assessment of Cancer Trial Generalizability in the Elderly
$422,334Elizabeth B Lamont · Harvard Medical School · R01 · FY2009 · CA
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment
$422,325Cheng-Kui Qu · Emory University · R01 · FY2021 · HL
Regulation and Targets of the DNA Damage Checkpoint
$422,324David P Toczyski · University Of California, San Francisco · R01 · FY2011 · GM
Generalizable Nanosensors for Probing Highly Specific Interactions of Protein Kinases
$422,233Liviu Movileanu · Syracuse University · R01 · FY2023 · GM
ALL immunobiology and the bone marrow niche
$422,227Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Aberrant Megakaryopoiesis in the Myeloproliferative Neoplasms
$422,223John D Crispino · Northwestern University At Chicago · R01 · FY2016 · HL
Deregulation of Cellular IkB Kinases by HTLV1 Tax
$422,216Dean Ballard · Vanderbilt University · R01 · FY2006 · CA
Project 1: Decoding, Modeling and Targeting Oncohistones and an Oncohistone-like Protein
$422,216Nada Jabado · Rockefeller University · P01 · FY2023 · CA
Engineering HIV-specific T cells that have improved function and persistence
$422,189E. John Wherry · University Of Pennsylvania · U19 · FY2024 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP
$422,179University Of Pennsylvania · U10 · FY2003 · CA
Genetic Dissection of Trisomy 21
$422,174Eugene Yu · Roswell Park Cancer Institute Corp · R01 · FY2009 · HL
Targeting leukemic stem cells in acute myeloid leukemia
$422,159Cheng-Kui Qu · Emory University · R01 · FY2025 · CA
Targeting leukemic stem cells in acute myeloid leukemia
$422,157Cheng-Kui Qu · Emory University · R01 · FY2023 · CA
Regulation and function of HOX genes in Ewing sarcoma pathogenesis
$422,132Elizabeth R Lawlor · Seattle Children'S Hospital · R01 · FY2022 · CA
Polycomb genes and keratinocyte function
$422,086Richard L Eckert · University Of Maryland Baltimore · R01 · FY2008 · AR
Mouse Model of Sickle Cell Disease and Genetic Therapies
$422,085Tim M. Townes · University Of Alabama At Birmingham · R01 · FY2007 · HL